Upregulation of Sortilin, a Lysosomal Sorting Receptor, Corresponds with Reduced Bioavailability of Latent TGFβ in Mucolipidosis II Cells

Mucolipidosis II (ML-II) is a lysosomal disease caused by defects in the carbohydrate-dependent sorting of soluble hydrolases to lysosomes. Altered growth factor signaling has been identified as a contributor to the phenotypes associated with ML-II and other lysosomal disorders but an understanding...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Jarrod W., Aarnio-Peterson, Megan, Norris, Joy, Haskins, Mark, Flanagan-Steet, Heather, Steet, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277838/
https://www.ncbi.nlm.nih.gov/pubmed/32357547
http://dx.doi.org/10.3390/biom10050670
_version_ 1783543211889786880
author Barnes, Jarrod W.
Aarnio-Peterson, Megan
Norris, Joy
Haskins, Mark
Flanagan-Steet, Heather
Steet, Richard
author_facet Barnes, Jarrod W.
Aarnio-Peterson, Megan
Norris, Joy
Haskins, Mark
Flanagan-Steet, Heather
Steet, Richard
author_sort Barnes, Jarrod W.
collection PubMed
description Mucolipidosis II (ML-II) is a lysosomal disease caused by defects in the carbohydrate-dependent sorting of soluble hydrolases to lysosomes. Altered growth factor signaling has been identified as a contributor to the phenotypes associated with ML-II and other lysosomal disorders but an understanding of how these signaling pathways are affected is still emerging. Here, we investigated transforming growth factor beta 1 (TGFβ1) signaling in the context of ML-II patient fibroblasts, observing decreased TGFβ1 signaling that was accompanied by impaired TGFβ1-dependent wound closure. We found increased intracellular latent TGFβ1 complexes, caused by reduced secretion and stable localization in detergent-resistant lysosomes. Sortilin, a sorting receptor for hydrolases and TGFβ-related cytokines, was upregulated in ML-II fibroblasts as well as GNPTAB-null HeLa cells, suggesting a mechanism for inappropriate lysosomal targeting of TGFβ. Co-expression of sortilin and TGFβ in HeLa cells resulted in reduced TGFβ1 secretion. Elevated sortilin levels correlated with normal levels of cathepsin D in ML-II cells, consistent with a compensatory role for this receptor in lysosomal hydrolase targeting. Collectively, these data support a model whereby sortilin upregulation in cells with lysosomal storage maintains hydrolase sorting but suppresses TGFβ1 secretion through increased lysosomal delivery. These findings highlight an unexpected link between impaired lysosomal sorting and altered growth factor bioavailability.
format Online
Article
Text
id pubmed-7277838
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72778382020-06-12 Upregulation of Sortilin, a Lysosomal Sorting Receptor, Corresponds with Reduced Bioavailability of Latent TGFβ in Mucolipidosis II Cells Barnes, Jarrod W. Aarnio-Peterson, Megan Norris, Joy Haskins, Mark Flanagan-Steet, Heather Steet, Richard Biomolecules Article Mucolipidosis II (ML-II) is a lysosomal disease caused by defects in the carbohydrate-dependent sorting of soluble hydrolases to lysosomes. Altered growth factor signaling has been identified as a contributor to the phenotypes associated with ML-II and other lysosomal disorders but an understanding of how these signaling pathways are affected is still emerging. Here, we investigated transforming growth factor beta 1 (TGFβ1) signaling in the context of ML-II patient fibroblasts, observing decreased TGFβ1 signaling that was accompanied by impaired TGFβ1-dependent wound closure. We found increased intracellular latent TGFβ1 complexes, caused by reduced secretion and stable localization in detergent-resistant lysosomes. Sortilin, a sorting receptor for hydrolases and TGFβ-related cytokines, was upregulated in ML-II fibroblasts as well as GNPTAB-null HeLa cells, suggesting a mechanism for inappropriate lysosomal targeting of TGFβ. Co-expression of sortilin and TGFβ in HeLa cells resulted in reduced TGFβ1 secretion. Elevated sortilin levels correlated with normal levels of cathepsin D in ML-II cells, consistent with a compensatory role for this receptor in lysosomal hydrolase targeting. Collectively, these data support a model whereby sortilin upregulation in cells with lysosomal storage maintains hydrolase sorting but suppresses TGFβ1 secretion through increased lysosomal delivery. These findings highlight an unexpected link between impaired lysosomal sorting and altered growth factor bioavailability. MDPI 2020-04-26 /pmc/articles/PMC7277838/ /pubmed/32357547 http://dx.doi.org/10.3390/biom10050670 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Barnes, Jarrod W.
Aarnio-Peterson, Megan
Norris, Joy
Haskins, Mark
Flanagan-Steet, Heather
Steet, Richard
Upregulation of Sortilin, a Lysosomal Sorting Receptor, Corresponds with Reduced Bioavailability of Latent TGFβ in Mucolipidosis II Cells
title Upregulation of Sortilin, a Lysosomal Sorting Receptor, Corresponds with Reduced Bioavailability of Latent TGFβ in Mucolipidosis II Cells
title_full Upregulation of Sortilin, a Lysosomal Sorting Receptor, Corresponds with Reduced Bioavailability of Latent TGFβ in Mucolipidosis II Cells
title_fullStr Upregulation of Sortilin, a Lysosomal Sorting Receptor, Corresponds with Reduced Bioavailability of Latent TGFβ in Mucolipidosis II Cells
title_full_unstemmed Upregulation of Sortilin, a Lysosomal Sorting Receptor, Corresponds with Reduced Bioavailability of Latent TGFβ in Mucolipidosis II Cells
title_short Upregulation of Sortilin, a Lysosomal Sorting Receptor, Corresponds with Reduced Bioavailability of Latent TGFβ in Mucolipidosis II Cells
title_sort upregulation of sortilin, a lysosomal sorting receptor, corresponds with reduced bioavailability of latent tgfβ in mucolipidosis ii cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277838/
https://www.ncbi.nlm.nih.gov/pubmed/32357547
http://dx.doi.org/10.3390/biom10050670
work_keys_str_mv AT barnesjarrodw upregulationofsortilinalysosomalsortingreceptorcorrespondswithreducedbioavailabilityoflatenttgfbinmucolipidosisiicells
AT aarniopetersonmegan upregulationofsortilinalysosomalsortingreceptorcorrespondswithreducedbioavailabilityoflatenttgfbinmucolipidosisiicells
AT norrisjoy upregulationofsortilinalysosomalsortingreceptorcorrespondswithreducedbioavailabilityoflatenttgfbinmucolipidosisiicells
AT haskinsmark upregulationofsortilinalysosomalsortingreceptorcorrespondswithreducedbioavailabilityoflatenttgfbinmucolipidosisiicells
AT flanagansteetheather upregulationofsortilinalysosomalsortingreceptorcorrespondswithreducedbioavailabilityoflatenttgfbinmucolipidosisiicells
AT steetrichard upregulationofsortilinalysosomalsortingreceptorcorrespondswithreducedbioavailabilityoflatenttgfbinmucolipidosisiicells